Opposite effects of allergy prevention depending on CD14 rs2569190 genotype in 3 intervention studies - 24/12/11
The PIAMA study is supported by the Dutch Asthma Foundation (grants 3.4.01.26, 3.2.06.022, 37 3.4.09.081, and 3.2.10.085CO), the ZON-MW Netherlands Organization for Health Research and Development (grant 912-03-031), the Stichting Astmabestrijding, and the Ministry of the Environment. CAPPS was funded by the Canadian Institutes for Health Research; AllerGen NCE, Inc (the Allergy, Genes and Environment Network), a member of the Networks of the Centres of Excellence Canada program; and a grant from the BC Chapter of the Canadian Lung association (to D.D.). D.D. is the recipient of a Michael Smith Foundation for Health Research (MSFHR) Career Scholar Award and holds a Tier II Canadian Research Chair appointment. |
|
Disclosure of potential conflict of interest: D. Daley receives research support from the AllerGen National Center of Excellence, the Canadian Institutes for Health Research, and the Canadian Lung Association of British Columbia. D. S. Postma has consultant arrangements with Nycomed, GlaxoSmithKline, and AstraZeneca. A. Becker receives research support from the Canadian Institutes for Health Research. G. H. Koppelman receives research support from the Netherlands Asthma Foundation and GlaxoSmithKline. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 129 - N° 1
P. 256-259 - janvier 2012 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?